Rapatar

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameRapatar
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEveron Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesEveron Biosciences
Inactive CompaniesN/A
Active IndicationsReperfusion Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A